Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients - Trial NCT05899543
Access comprehensive clinical trial information for NCT05899543 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Chronic Lymphocytic Leukemia. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Power Life Sciences Inc.
Timeline & Enrollment
N/A
Jul 01, 2024
Jul 01, 2026
Primary Outcome
Number of chronic lymphocytic leukemia patients who decide to join in a clinical study,Rate of patients who remain in an chronic lymphocytic leukemia clinical study to completion
Summary
This research study aims to address the limited understanding of the challenges faced by
 specific demographic groups of chronic lymphocytic leukemia patients in their participation
 in clinical trials.
 
 This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic
 leukemia as they take part in a separate medical intervention clinical trial. The focus will
 be on tracking the rates of completion and withdrawal among these individuals.
 
 It will also try to analyze data from the perspective of different demographic groups to
 check for recurring trends which might yield insights for the sake of future chronic
 lymphocytic leukemia patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05899543
Non-Device Trial